Rhythm Pharmaceuticals, Inc 10-K for FY2022
Rhythm Pharmaceuticals, Inc. (RYTM)
10-K
2023-03-01
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
Rhythm Pharmaceuticals, Inc filed this 10-K on March 1, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $23.64M
- up 649.5% from $3.15M a year earlier
- Net loss
- $181.12M
- compared with a net loss of $69.61M a year earlier
- Diluted EPS
- -$3.47
- compared with -$1.40 a year earlier